151 related articles for article (PubMed ID: 2643042)
1. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
2. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.
Parfrey PS; Griffiths SM; Barrett BJ; Paul MD; Genge M; Withers J; Farid N; McManamon PJ
N Engl J Med; 1989 Jan; 320(3):143-9. PubMed ID: 2643041
[TBL] [Abstract][Full Text] [Related]
3. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Tepel M; van der Giet M; Schwarzfeld C; Laufer U; Liermann D; Zidek W
N Engl J Med; 2000 Jul; 343(3):180-4. PubMed ID: 10900277
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients.
Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816
[TBL] [Abstract][Full Text] [Related]
5. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate.
Gale ME; Robbins AH; Hamburger RJ; Widrich WC
AJR Am J Roentgenol; 1984 Feb; 142(2):333-5. PubMed ID: 6607603
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
[TBL] [Abstract][Full Text] [Related]
7. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
Marenzi G; Marana I; Lauri G; Assanelli E; Grazi M; Campodonico J; Trabattoni D; Fabbiocchi F; Montorsi P; Bartorelli AL
N Engl J Med; 2003 Oct; 349(14):1333-40. PubMed ID: 14523141
[TBL] [Abstract][Full Text] [Related]
8. [Nephrotoxicity of iodine contrast media].
Meyrier A
Ann Radiol (Paris); 1994; 37(4):286-95. PubMed ID: 8085753
[TBL] [Abstract][Full Text] [Related]
9. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
[TBL] [Abstract][Full Text] [Related]
10. The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents.
Buyan N; Arab M; Hasanoğlu E; Gökçora N; Ercan S
Turk J Pediatr; 1995; 37(4):305-13. PubMed ID: 8560597
[TBL] [Abstract][Full Text] [Related]
11. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.
Davidson CJ; Hlatky M; Morris KG; Pieper K; Skelton TN; Schwab SJ; Bashore TM
Ann Intern Med; 1989 Jan; 110(2):119-24. PubMed ID: 2909204
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents.
Deray G; Bellin MF; Boulechfar H; Baumelou B; Koskas F; Baumelou A; Grellet J; Jacobs C
Am J Nephrol; 1991; 11(4):309-12. PubMed ID: 1799190
[TBL] [Abstract][Full Text] [Related]
14. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
Kurnik BR; Weisberg LS; Cuttler IM; Kurnik PB
J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
[TBL] [Abstract][Full Text] [Related]
15. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography.
Taliercio CP; Vlietstra RE; Ilstrup DM; Burnett JC; Menke KK; Stensrud SL; Holmes DR
J Am Coll Cardiol; 1991 Feb; 17(2):384-90. PubMed ID: 1991894
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents.
Harris KG; Smith TP; Cragg AH; Lemke JH
Radiology; 1991 Jun; 179(3):849-52. PubMed ID: 2028004
[TBL] [Abstract][Full Text] [Related]
18. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
Denys BG; Reddy PS; Uretsky BF
Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
